Frontiers in Medicine (Jan 2023)

18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice

  • Kladoum Nassarmadji,
  • Anthony Vanjak,
  • Venceslas Bourdin,
  • Karine Champion,
  • Ruxandra Burlacu,
  • Stéphane Mouly,
  • Damien Sène,
  • Cloé Comarmond

DOI
https://doi.org/10.3389/fmed.2023.1103752
Journal volume & issue
Vol. 10

Abstract

Read online

Diagnosis, prognostic assessment, and monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging. Early recognition of LVV and treatment adaptation is essential because vascular complications (aneurysm, dilatations, ischemic complications) or treatment related side effects can occur frequently in these patients. 18-fluorodeoxyglucose positron emission tomography/computed tomography (2-[18F]FDG-PET/CT) is increasingly used to diagnose, follow, and evaluate treatment response in LVV. In this review, we aimed to summarize the current evidence on the value of 2-[18F]FDG-PET/CT for diagnosis, follow, and treatment monitoring in LVV.

Keywords